Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies

Overview of attention for article published in Frontiers in Pharmacology, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,638 followers.

We've detected a paper from Frontiers in Pharmacology that cites a retracted paper post-retraction. Citing paper: https://t.co/DyyjqJg7Jj Retracted paper: https://t.co/vz7ywu0a9f

15 Apr 2023

Reply Repost Favourite

Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies https://t.co/Nodlk1ewwU

03 Mar 2023

Reply Repost Favourite

New Research: Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies https://t.co/2gzTNR4R71 #pharmacology

14 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.